Home / Business and Economy / Kimberly-Clark Buys Tylenol Maker Kenvue in $48.7B Deal
Kimberly-Clark Buys Tylenol Maker Kenvue in $48.7B Deal
3 Nov, 2025
Summary
- Kimberly-Clark to acquire Kenvue, owner of Tylenol, for $40B
- Kenvue shareholders to receive $3.50 per share in cash and 0.14625 Kimberly-Clark shares
- Combined company to be 54% owned by current Kimberly-Clark shareholders
On November 3, 2025, Kimberly-Clark, the maker of Kleenex and Huggies, announced that it has agreed to acquire Kenvue, the consumer-health company that owns popular brands like Tylenol, in a $40 billion cash and stock deal.
The transaction, which has an enterprise value of approximately $48.7 billion, will see Kenvue shareholders receive $3.50 per share in cash and 0.14625 Kimberly-Clark shares for each Kenvue share they own. Based on Kimberly-Clark's closing price on the previous Friday, the total consideration per Kenvue share amounts to $21.01.
Following the completion of the deal, current Kimberly-Clark shareholders will own around 54% of the combined company, with Kenvue shareholders owning the remaining 46%. The acquisition is expected to strengthen Kimberly-Clark's position in the consumer-health market and provide synergies that will benefit the combined entity.
